What is the indicative price of API Holdings (PharmEasy) unlisted shares?

The indicative price shown for API Holdings (PharmEasy) on BRAND is ₹28 per share (as displayed on this page). This is not an exchange-traded last price. The final price is confirmed by our team based on availability, lot size, and market conditions at the time of the transaction. This is not investment advice.

How can I buy API Holdings (PharmEasy) unlisted shares?

Submit an enquiry on this page with your contact details and preferred quantity. An advisor will confirm availability, pricing, documentation, and next steps for API Holdings (PharmEasy). Typical lot size shown here is 200 share(s), with an indicative minimum around ₹5,600. This is not investment advice.

What are the main risks of API Holdings (PharmEasy) unlisted shares?

API Holdings (PharmEasy) unlisted shares can be illiquid, hard to value precisely, and may not list via IPO. You can lose some or all of your capital. Prices on this site are indicative only. BRAND is not a SEBI-recognised stock exchange. This is not investment advice.

Is there a lock-in or IPO timeline for API Holdings (PharmEasy)?

Some unlisted holdings may carry contractual or regulatory lock-in or transfer restrictions. There is no guarantee that API Holdings (PharmEasy) will list on a stock exchange or that an IPO will occur on any particular timeline. Always confirm terms with an advisor before you commit. This is not investment advice.

API Holdings (PharmEasy) Unlisted Share Price | Buy API Holdings (PharmEasy) Unlisted Shares

HealthcareIndicative

Indicative price

₹28

-5.2% · 30d

Lot size: 200
Minimum investment: ₹5,600

Prices are indicative and may differ at execution. Last updated 23 Oct 2026.

Indicative price history

Sample series for layout only—not live market history.

Key facts

Placeholder company fields for layout—verify before relying on them.

Sector: Healthcare
ISIN: INEPHARME0101
Face value: ₹1
Lot size: 200
52-week high: ₹30
52-week low: ₹24
Market cap: PLACEHOLDER — ₹2,200 Cr
Last funding: PLACEHOLDER — Late-stage / secondary (indicative)
Founded: 2015
Headquarters: Mumbai, India

About the company

PLACEHOLDER — API Holdings (PharmEasy) is shown with sample healthcare marketplace context. Replace with verified business description.

Business highlights

PLACEHOLDER — Established operating presence in its core market.
PLACEHOLDER — Indicative pricing shown on this site is not exchange-traded.
PLACEHOLDER — Lot size and availability can change by counterparty.

Financials

Sample figures (₹ crore) for UI only—not audited statements.

Metric	FY23	FY24	FY25
Revenue	₹420 Cr	₹510 Cr	₹585 Cr
Profit	₹48 Cr	₹61 Cr	₹74 Cr
EBITDA	₹92 Cr	₹118 Cr	₹141 Cr

Shareholding pattern

Sample ownership mix for UI—confirm against company disclosures.

Total

100%

Promoters52%
Institutions18%
Public22%
Others8%

Strengths and risks

Balanced, factual notes for context. This is not investment advice.

Strengths

PLACEHOLDER — Recognisable brand or franchise in its category.
PLACEHOLDER — Documented financial trajectory on sample filings shown below.

Risks

Liquidity risk: unlisted shares can be hard to sell quickly or at the indicative price.
Valuation risk: indicative prices are negotiated and may differ materially at execution.
PLACEHOLDER — Information asymmetry versus listed peers; filings may be limited.
PLACEHOLDER — Business, regulatory, or sector-specific risks may affect outcomes.

Enquire

Talk to an advisor

Share your details for API Holdings (PharmEasy). We will confirm availability and an indicative price.

Other unlisted names you may want to explore. Prices are indicative only.

View sector

NSFinancial Services
NSE India
Indicative price
₹1,850
+4.2%
Minimum investment · 1 × ₹1,850
₹1,850
Details Enquire
RRConsumer
Reliance Retail
Indicative price
₹1,420
-1.8%
Minimum investment · 5 × ₹1,420
₹7,100
Details Enquire
TCNBFC
Tata Capital
Indicative price
₹980
+6.5%
Minimum investment · 10 × ₹980
₹9,800
Details Enquire

Indicative · API Holdings (PharmEasy)

₹28

-5.2%

Loading share…

Metric

FY23

FY24

FY25

Revenue

₹420 Cr

₹510 Cr

₹585 Cr

Profit

₹48 Cr

₹61 Cr

₹74 Cr

EBITDA

₹92 Cr

₹118 Cr

₹141 Cr

Talk to an advisor

Share your details for API Holdings (PharmEasy). We will confirm availability and an indicative price.

API Holdings (PharmEasy) Unlisted Shares

Indicative price history

Key facts

About the company

Business highlights

Financials

Shareholding pattern

Strengths and risks

Strengths

Risks

Talk to an advisor

Related unlisted shares

NSE India

Reliance Retail

Tata Capital

Questions about API Holdings (PharmEasy)

What is the indicative price of API Holdings (PharmEasy) unlisted shares?

How can I buy API Holdings (PharmEasy) unlisted shares?

What are the main risks of API Holdings (PharmEasy) unlisted shares?

Is there a lock-in or IPO timeline for API Holdings (PharmEasy)?

API Holdings (PharmEasy) Unlisted Shares

Indicative price history

Key facts

About the company

Business highlights

Financials

Shareholding pattern

Strengths and risks

Strengths

Risks

Talk to an advisor

Related unlisted shares

NSE India

Reliance Retail

Tata Capital

Questions about API Holdings (PharmEasy)

What is the indicative price of API Holdings (PharmEasy) unlisted shares?

How can I buy API Holdings (PharmEasy) unlisted shares?

What are the main risks of API Holdings (PharmEasy) unlisted shares?

Is there a lock-in or IPO timeline for API Holdings (PharmEasy)?